26888921|t|Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy.
26888921|a|Tauopathies are neurodegenerative diseases characterized by intraneuronal inclusions of hyperphosphorylated tau protein and abnormal expression of brain-derived neurotrophic factor (BDNF), a key modulator of neuronal survival and function. The severity of both these pathological hallmarks correlate with the degree of cognitive impairment in patients. However, how tau pathology specifically modifies BDNF signaling and affects neuronal function during early prodromal stages of tauopathy remains unclear. Here, we report that the mild tauopathy developing in retinal ganglion cells (RGCs) of the P301S tau transgenic (P301S) mouse induces functional retinal changes by disrupting BDNF signaling via the TrkB receptor. In adult P301S mice, the physiological visual response of RGCs to pattern light stimuli and retinal acuity decline significantly. As a consequence, the activity-dependent secretion of BDNF in the vitreous is impaired in P301S mice. Further, in P301S retinas, TrkB receptors are selectively upregulated, but uncoupled from downstream extracellular signal-regulated kinase (ERK) 1/2 signaling. We also show that the impairment of TrkB signaling is triggered by tau pathology and mediates the tau-induced dysfunction of visual response. Overall our results identify a neurotrophin-mediated mechanism by which tau induces neuronal dysfunction during prodromal stages of tauopathy and define tau-driven pathophysiological changes of potential value to support early diagnosis and informed therapeutic decisions. SIGNIFICANCE STATEMENT: This work highlights the potential molecular mechanisms by which initial tauopathy induces neuronal dysfunction. Combining clinically used electrophysiological techniques (i.e., electroretinography) and molecular analyses, this work shows that in a relevant model of early tauopathy, the retina of the P301S mutant human tau transgenic mouse, mild tau pathology results in functional changes of neuronal activity, likely due to selective impairment of brain-derived neurotrophic factor signaling via its receptor, TrkB. These findings may have important translational implications for early diagnosis in a subset of Alzheimer's disease patients with early visual symptoms and emphasize the need to clarify the pathophysiological changes associated with distinct tauopathy stages to support informed therapeutic decisions and guide drug discovery.
26888921	0	3	Tau	Gene	4137
26888921	11	48	Neuronal and Neurotrophic Dysfunction	Disease	MESH:D009133
26888921	54	59	Mouse	Species	10090
26888921	75	84	Tauopathy	Disease	MESH:D024801
26888921	86	97	Tauopathies	Disease	MESH:D024801
26888921	102	128	neurodegenerative diseases	Disease	MESH:D019636
26888921	194	197	tau	Gene	4137
26888921	233	266	brain-derived neurotrophic factor	Gene	627
26888921	268	272	BDNF	Gene	627
26888921	405	425	cognitive impairment	Disease	MESH:D003072
26888921	429	437	patients	Species	9606
26888921	452	455	tau	Gene	4137
26888921	488	492	BDNF	Gene	12064
26888921	566	575	tauopathy	Disease	MESH:D024801
26888921	623	632	tauopathy	Disease	MESH:D024801
26888921	684	689	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
26888921	690	693	tau	Gene	4137
26888921	706	711	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
26888921	713	718	mouse	Species	10090
26888921	768	772	BDNF	Gene	12064
26888921	815	820	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
26888921	821	825	mice	Species	10090
26888921	990	994	BDNF	Gene	12064
26888921	1026	1031	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
26888921	1032	1036	mice	Species	10090
26888921	1050	1055	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
26888921	1139	1186	extracellular signal-regulated kinase (ERK) 1/2	Gene	26417;26413
26888921	1234	1238	TrkB	Gene	18212
26888921	1265	1268	tau	Gene	4137
26888921	1296	1299	tau	Gene	4137
26888921	1308	1338	dysfunction of visual response	Disease	MESH:D014786
26888921	1412	1415	tau	Gene	4137
26888921	1424	1444	neuronal dysfunction	Disease	MESH:D009461
26888921	1472	1481	tauopathy	Disease	MESH:D024801
26888921	1493	1496	tau	Gene	4137
26888921	1710	1719	tauopathy	Disease	MESH:D024801
26888921	1728	1748	neuronal dysfunction	Disease	MESH:D009461
26888921	1910	1919	tauopathy	Disease	MESH:D024801
26888921	1939	1944	P301S	ProteinMutation	tmVar:p|SUB|P|301|S;HGVS:p.P301S;VariantGroup:0;CorrespondingGene:4137;RS#:63751438;CorrespondingSpecies:9606;CA#:225439
26888921	1952	1957	human	Species	9606
26888921	1958	1961	tau	Gene	4137
26888921	1973	1978	mouse	Species	10090
26888921	1985	1988	tau	Gene	4137
26888921	2089	2122	brain-derived neurotrophic factor	Gene	12064
26888921	2151	2156	TrkB.	Gene	18212
26888921	2253	2272	Alzheimer's disease	Disease	MESH:D000544
26888921	2273	2281	patients	Species	9606
26888921	2293	2308	visual symptoms	Disease	MESH:D014786
26888921	2399	2408	tauopathy	Disease	MESH:D024801
26888921	Association	MESH:D024801	RS#:63751438;HGVS:p.P301S;CorrespondingGene:4137
26888921	Association	MESH:D024801	627
26888921	Association	MESH:D009133	4137
26888921	Association	12064	4137
26888921	Negative_Correlation	18212	4137
26888921	Association	MESH:D000544	18212
26888921	Association	MESH:D009461	4137
26888921	Positive_Correlation	MESH:D014786	4137
26888921	Association	MESH:D014786	18212
26888921	Association	MESH:D024801	12064
26888921	Bind	12064	18212
26888921	Association	MESH:D024801	4137
26888921	Association	MESH:D024801	4137

